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Abstract
Background: Previous studies have demonstrated that alterations in certain circulating biomarkers may be
correlated with Coal workers’ pneumoconiosis (CWP). This study investigated the relationship between changes of
serum biomarkers and pulmonary function during the development of CWP.
Methods: Lung function parameters and specific serum indices were measured in 69 non-smoking coal workers,
including 34 miners with CWP, 24 asymptomatic miners and 11 miners with minimal symptoms. The associations
between changes in pulmonary function and serum indices were tested with Pearson’s correlation coefficients.
Multivariable analysis was used to estimate the predictive power of potential determinant variables for lung
function.
Results: Compared to healthy miners, lung function (FVC, FEV1, FEF50, FEF75, FEF25-75 % of predicted values) was
decreased in miners with CWP (p < 0.05). Increased serum matrix metalloproteinase-9 (MMP-9) was associated with
decreased FVC% of predicted values in the asymptomatic miners (r = -0.503, p = 0.014).
Conclusions: In coal mine workers, alterations of lung function parameters are associated with the development of
CWP and with changes in circulating MMP-9, TIMP-9, IL-13 and IL-18R. These serum biomarkers may likely reflect
the pathogenesis and progression of CWP in coal workers, and may provide for the importance of serum indicators
in the early diagnosis of lung function injury in coal miners.
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Background
Despite implementation of rules and regulations for safer
limits to dust exposure in the workplace, Coal workers’
pneumoconiosis (CWP) is still an occupational health
problem [1,2]. Coal miners with pneumoconiosis often
experience symptoms such as chronic cough, sputum
production and episodes of wheezing, which suggests the
presence of airway dysfunction. Ventilatory defect is a
common finding among miners with CWP [3].
Although pathophysiological mechanisms have not
been elucidated, it has been proposed that following
exposure to coal dust, lung tissue responds subsequently
in a series of three steps: activation and accumulation of
inflammatory cells [4]; activation and proliferation of
fibroblasts [5]; and enhanced accumulation of mesench-
ymal cells and production of collagen [6]. Each of these
steps involves a complex interplay of diverse cell types
and mediators, including cytokines and other biomar-
kers that have been implicated as participants in these
processes.
It has been previously reported that interleukin-1beta
(IL-1b), IL-8, IL-18 and monocyte chemoattractant pro-
tein-1 (MCP-1) are important in recruiting and activating
leukocytes, and also in pro-inflammatory cytokine produc-
tion [7-10]. The Th2 cytokine IL-13 may be involved in
inflammation and remodeling, which accompanies lung
fibrosis [11], while the antifibrotic effects of IL-9 may be
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observed in pulmonary fibrosis [12].
Similarly, intercellular adhesion molecule-1 (ICAM-1),
CD40, and CD40 ligand (CD40L) have been documen-
ted in localized tissue inflammation and fibrotic
responses [13-15]. Matrix metalloproteinases (MMPs),
which are initiators of the enzymatic degradation pro-
cess of extracellular matrix, are critical in the tissue
remodeling process [16,17]. Elevated levels of MMPs
have been noted during early stages of pulmonary silica
exposure [18].
Studies of pulmonary fibrosis-sensitive mice have
shown positive correlations between tissue and serum
cytokine levels, suggesting that blood indices may be
used as surrogate markers for tissue cytokines [19]. Pre-
vious studies from our laboratory have demonstrated
that changes in serum IL-18, IL-18 receptor (IL-18R),
MCP-1, sICAM-1, MMP-9, and tissue inhibitors of
metalloproteinase-9 (TIMP-9) may be involved in the
pathogenesis of CWP [20-24], but little is known about
the association between these serum biomarkers and
lung function impairment.
We hypothesized that the alterations in serum bio-
markers were related to pulmonary function impairment
in CWP. To test this possibility, spirometry parameters
of expiratory flow lung capacity FVC, FEV1,F E F 25,
FEF50,F E F 75,F E F 25-75 and FEV1/FVC were determined
as clinical evidence of respiratory injury [25]. The asso-
ciations between these lung function parameters and
levels of serum biomarkers (IL-1b, IL-8, IL-9, IL-13, IL-
18, IL-18R, MCP-1, sICAM-1, MMP-9, TIMP-9, sCD40,
and sCD40L) were analyzed in non-smoking coal work-
ers with CWP and two matched control groups, asymp-
tomatic miners and miners with minimal symptoms
(group 0+).
Methods
Subjects
Coal miners were physically examined and history of
clinical conditions and smoking habits were assessed at
the Kai Luan Prevention and Treatment Institute of
Occupational Disease from March 1 to December 30 of
2008. Those study subjects selected were all non-smok-
ing males working under similar mine environmental
conditions, having normal liver and kidney function
with no coronary artery disease, hypertension, diabetes
mellitus or autoimmune disease. None of the subjects
reported any recent or current infection.
A posteroanterior chest radiograph was taken on each
subject. Two experienced physicians read the radiologi-
cal appearances following the diagnostic criteria of
pneumoconiosis GBZ 70-2002 [26], and three Categories
of the lung condition were determined as follows: Cate-
gory 1, few small opacities present, distribution to at
least two areas of lung; Category 2, numerous small
opacities present, distribution to more than four areas
of lung; Category 3, a large opacity present, not less
than 20 mm × 10 mm in size. Asymptomatic miners
were those subjects who had chest radiographs without
evidence of pneumoconiosis. Group 0
+ miners were
those subjects who had chest radiographs with only bor-
derline evidence of pneumoconiosis-like opacities that
were not definitive enough to be diagnosed as pneumo-
coniosis category 1.
According to the diagnostic criteria, 40 miners with
CWP category 1 and 20 miners from group 0+ were
recruited; 25 matched asymptomatic miners were also
selected randomly for the study. Excluding missing data
due to inappropriate cooperation in the lung function
test, and insufficient or haemolysis samples, 69 subjects
completed the study. Theses study subjects included 34
miners with CWP stage 1, 11 group 0+ miners, and 24
asymptomatic miners.
This study was approved by the Ethics Committee of
the Attached Kai Luan Hospital of North China Coal
Medical College. Informed consent was obtained from
all study subjects.
Pulmonary ventilation function tests
Spirometry tests were performed by trained personnel
utilizing an automatic pulmonary functions testing sys-
tem, the Masterscreen PFT (JAEGER, Germany). Lung
ventilation function parameters were measured from
each subject in this study. These parameters included
the percent predicted values for forced vital capacity
(FVC), forced expiratory volume in 1 second (FEV1),
forced expiratory flow after 25% of vital capacity has
been expelled (FEF25), forced expiratory flow after 50%
of vital capacity has been expelled (FEF50), forced
expiratory flow after 75% of vital capacity has been
expelled (FEF75), forced expiratory flow from 25% to
75% of vital capacity (FEF25-75), and the percentage of
FEV1 to FVC (FEV1/FVC).
Serum biomarkers analysis
Serum concentrations of IL-1b, IL-8, IL-13, IL-9, IL18,
I L - 1 8 R ,M C P - 1 ,s I C A M - 1 ,M M P - 9 ,T I M P - 9 ,s C D 4 0 ,
and sCD40L in all of the coal miner subjects were deter-
mined according to the manufacturer’s instructions
using commercially available ELISA kits (R&D Systems).
The concentrations of sera indices were calculated by
comparing the values measured with a standard curve
constructed using known concentrations of the corre-
sponding indices.
Statistical analysis
All data were analyzed with the SPSS16 software. Lung
ventilation function parameters, except for the FEV1/
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values (% p). The lung function parameters were of nor-
mal distribution; the differences among groups (mean ±
SD) were examined with ANOVA and the Tukey-Kra-
mer multiple comparisons tests.
Serum IL-1b, IL-8, IL-13, IL-18R, sICAM-1, TIMP-9
and sCD40L were of normal distribution. Logarithm
transformations were performed on MMP-9, MCP-1,
IL-9, IL18 and sCD40 before statistical analysis.
Pearson’s correlation coefficients were calculated to
examine the strength of association between the lung
function parameters and the levels of serum factors.
Multiple stepwise analyses were used to estimate the
predictive power of potential determinants for lung
function in different groups respectively; p < 0.05 was
considered as statistically significant.
Results
The demographic characteristics of the three groups of
the coal miners are presented in Table 1. In order to
minimize the selection bias, we compared the distribu-
tion of characteristics, including age and dust-exposed
time, and there were no significant differences among
the three groups.
Comparisons of lung ventilation functional parameters
among CWP and control groups
A ss h o w ni nF i g u r e1 ,w h e nc o m p a r e dw i t ht h ed a t a
from asymptomatic miners, most of the lung ventila-
tion functional parameters were in a decreasing trend
in patients with CWP. The FVC, FEV1,F E F 50,F E F 75
and FEF25-75 values were significantly decreased
(p = 0.033, 0.035, 0.024, 0.037, and 0.017, respectively),
while FEV1/FVC and FEF25 showed no significant dif-
ferences. When the same parameters of group 0+ were
compared with asymptomatic miners, the values were
in a decreasing trend but not significant (Figure 1).
Except for FVC and FEF25,t h eF E V 1/FVC, FEF50,
FEF75,F E F 25-75 and FEV1 parameters showed decreas-
ing trends in patients with CWP when compared with
group 0+, but there was also no significant difference
(Figure 1).
Correlations of lung ventilation functional parameters
and levels of serum biomarkers in asymptomatic miners
The results of Pearson’s correlation analysis indicated
that serum levels of IL-18 in the asymptomatic miners
showed a trend towards positive association with all
lung ventilation functional parameters; on the other
hand, levels of IL-18R, sCD40, sCD40L, MMP-9, TIMP-
9 and sICAM-1 showed a trend towards inverse associa-
tion with all lung ventilation function parameters.
Besides these findings, levels of MCP-1, IL-1b,I L - 8 ,I L -
13 and IL-9 did not show any relationship with lung
ventilation functional parameters in asymptomatic
miners.
With respect to MMP-9 in the asymptomatic group,
decreases of FVC values were correlated with the
increased levels of MMP-9 in these miners (r = -0.503,
p = 0.014). In addition, as shown in Table 2 the results
of multiple stepwise analyses indicated that the decrease
of FVC values was significantly associated with the
increased MMP-9 values in the asymptomatic miners.
Correlations of lung ventilation functional parameters
and serum biomarker levels in group 0+ miners
The results of Pearson’s correlation analysis showed that
in the group 0+ subjects, the increased serum TIMP-9
levels were significantly correlated with increased FEF25
values in these miners (r = 0.710, p = 0.014). Serum
levels of IL-13 and MMP-9 showed inverse associations
with all ventilation function parameters, and increased
IL-13 levels were significantly correlated with decreased
FEV1/FVC and FEF25 values (r = -0.765, p = 0.010; r =
-0.672, p = 0.033, respectively); increased MMP-9 levels
were also significantly associated with decreased FVC
values (r = -0.620, p = 0.042).
The results of multiple regression analysis as shown in
Table 3 indicate that the decreases of FVC values in
these same subjects were significantly associated with
increases of serum MMP-9 values (p = 0.04); decreases
of FEV1/FVC were significantly associated with increases
of IL-13 values (p = 0.01); and decreases of FEF25 values
were associated with decreases of serum levels of TIMP-
9( p = 0.028). Furthermore, the results of multiple step-
wise analyses also indicated that serum TIMP-9 had the
strongest correlation and serum MMP-9 had the weak-
est correlation with the lung function parameters in
group 0+ miners.
In addition, with regards to the results of Pearson’s
correlation analysis, although serum levels of TIMP-9
a n ds C D 4 0 Li nt h eg r o u p0 +m i n e r ss h o w e dat r e n d
towards positive association with all ventilation func-
tional parameters, the serum levels of MCP-1, IL-1b, IL-
8, IL-18, IL-18R, IL-9, sCD40, sICAM-1 did not show
any trends of association with lung ventilation functional
parameters in this group.
Table 1 Demographic Characteristics of CWP and Control
Groups
Subjects Numbers Age
(yr, Mean ±
SD)
Exposure
duration
(yr, Mean ± SD)
CWP 34 58.2 ± 5.7 26.6 ± 5.4
Group 0+ 11 57.0 ± 5.0 28.5 ± 7.4
Asymptomatic
miners
24 57.8 ± 5.9 27.5 ± 6.8
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and serum biomarker levels in group CWP miners
The results of Pearson’s correlation analysis indicated
that serum levels of IL-18R in the CWP miners showed
trends towards positive associations with all ventilation
function parameters, and also enhancements in IL-18R
levels in the subjects with CWP were correlated with
increased FEV1 (Figure 2), FEF50,F E F 75 and FEF25-75
values (r =0 . 5 7 0 ,p < 0.0005; r = 0.406, p = 0.017; r =
0.392, p =0 . 0 2 2 ;r = 0.475, p = 0.004, respectively). How-
ever, multiple stepwise analyses of the same data suggest
that decreases of FEV1 were significantly associated with
decreases of serum IL-18R (Table 4). Other lung ventila-
tion function test parameters did not show significant
correlations with IL-18R levels in these subjects.
In addition, the results indicated that the levels of
serum sCD40Li nt h eC W Pg r o u ps h o w e dt r e n d s
towards inverse association with all lung ventilation
function parameters; however there was no significant
correlation. Serum levels of MCP-1, IL-1b, IL-8, IL-18,
IL-13, IL-9, MMP-9, TIMP-9, sCD40, and sICAM-1 in
the CWP miners did not show trends in relation to ven-
tilation functional parameters.
Discussion
This study demonstrated that the lung ventilation function
parameters, the percent predicted values for FVC, FEV1,
FEF50, FEF75 and FEF25-75, showed significant decreases in
patients with CWP when compared with the respective
values in the asymptomatic miners group. These results
were similar to those observed in previous studies [3].
Longitudinal studies in coal miners have shown that expo-
sure to coal mine dust contributes to a decline in FEV1
[27,28]. Mamuya et. al. also reported that exposure to coal
mine dust was associated with airway limitation as mea-
sured by FEV1/FVC and the predicted FEV1(%) [29]. By
comparing the three groups of miners in the present
study, our lung ventilation function data provide further
evidence that airway dysfunction may be a predominant
feature in the initial development and progression of the
lung disease associated with coal mining.
The present study also revealed that the alterations of
lung function parameters may be associated with the
changes in concentration of certain serum biomarkers in
these coal miner subjects.
MMP-9 is produced constitutively by neutrophils and
eosinophils [30,31]. It has been shown that coal dust
Figure 1 Comparisons of Lung Ventilation Functional Parameters among Patients with CWP and two Control Groups.T h ep e r c e n t
predicted values of FVC, FEV1, FEF50, FEF75, and FEF25-75 in patients with CWP were significantly decreased when compared with the respective
parameters in asymptomatic miners: compared with asymptomatic miners, p < 0.05.
Table 2 Multiple Stepwise Analysis of Dependent Variable by Lung Ventilation Functional Parameters and
Independent Variable by Serum Biomarker Levels in Asymptomatic Miners
Dependent Variable Independent Variable Unstandardized Coefficients Standardized Coefficients t p Value
FVC (% p) MMP-9 -0.154 -0.057 -2.677 0.014
Significance: p < 0.05
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and that MMP-9 may be released immediately when
these cells are exposed to coal dust [32]. If levels of
MMP-9 were continually stimulated to increase, MMP-9
could induce inflammation by activating IL-1b,a na u t o -
inducible cytokine central to the inflammatory reaction
[33]. These responses could participate in aberrant
remodeling processes which damage the extra cellular
matrix and may result in lung injury. Data from this
study suggest that MMP-9 may play a role in these pro-
cesses in coal mine workers and is consistent with the
proposition that MMP-9 participates in the development
of airway inflammation and pulmonary fibrosis in these
miners [34].
A previous study from our laboratory demonstrated
that levels of serum MMP-9 in asymptomatic miners
were significantly lower when compared with the levels
in healthy control subjects who had no coal dust expo-
sure [22]. Also, the levels of serum MMP-9 in group 0+
were elevated slightly when compared with the dust-
exposed control group [22]. This previous data supports
the results of the present study indicating that increases
of serum MMP-9 are related to the impairment of venti-
lation function, while decreases of MMP-9 levels are
correlated with better lung function parameters. These
results provide evidence of the correlation between
levels of MMP-9 and the progression of lung disease in
miners, and may serve as possible reasons why most
asymptomatic coal miners in our study did not develop
pneumoconiosis.
The results of this study also revealed that the
decrease of serum TIMP-9 levels was correlated with
decreased ventilation function parameters in the coal
miners with minimal symptoms. These findings are the
opposite of our previous study which demonstrated that
both TIMP-9 and MMP-9 levels in minimally sympto-
matic miners were elevated slightly when compared
with these levels in dust-exposed control miners [22].
These results indicated that TIMPs could be involved in
the compensatory responses to the increased serum
MMP levels in order to silence the MMP activity [35].
The present data provides evidence that MMP-9 may be
involved in the contribution of the impairment of venti-
lation function in coal miners. The balance between
MMP and TIMP activities in a particular microenviron-
ment seems to determine whether physiological homeo-
static extra cellular matrix remodeling or excessive
proteolysis and possible pathological consequences
occur [36]. Therefore, observations on the differences in
serum MMP-9 and TIMP-9 levels in group 0+ and
healthy miners might indicate that these serum biomar-
kers may play roles in the progression of lung disease,
and may provide for the importance of serum indicators
for early diagnosis of lung function injury in coal
miners.
Previous studies have demonstrated that the Th2 cyto-
kine IL-13 is a powerful in vivo regulator of tissue
remodeling with the ability to activate a variety of
MMPs and cathepsins, generating destructive and fibro-
tic structural responses in tissues [37]. Increased IL-13
production has been documented in a variety of diseases
characterized by inflammation and remodeling [38-40].
Data presented in our studies showed that the increased
concentrations of serum IL-13 were correlated with
decreased FEV1/FVC and FEF25 levels in group 0+
miners. These results are in agreement with an experi-
mental lung fibrosis study which confirmed that the
constitutive and/or inducible transgenic overexpression
of IL-13 in the murine lung induces airway inflamma-
tion involving macrophages, lymphocytes and eosino-
phils, airway remodeling with subepithelial fibrosis,
Table 3 Multiple Stepwise Analysis of Dependent Variable by Lung Ventilation Functional Parameters and
Independent Variable by Serum Biomarker Levels in Group 0+
Dependent Variable Independent Variable Unstandardized Coefficients Standardized Coefficients tp Value
FVC (% p) MMP-9 -0.098 -0.065 -2.449 0.040
FEV1/FVC (%) IL-13 -1.439 -0.428 -3.364 0.010
FEF25 (% p) TIMP-9 0.184 0.687 2.675 0.028
Significance: p < 0.05
Figure 2 Correlations of FEV1 and Serum Levels of IL-18R in
the Coal Workers. Scatter plot showed that decreased serum IL-
18R levels in the CWP subjects correlated with decreased FEV1 (r =
0.570, p < 0.0005) in patients with CWP. Serum levels of IL-18R
showed an inverse trend association with FEV1 in asymptomatic
miners and group 0+ miners.
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increases in alveolar size, lung size, and pulmonary com-
pliance [37]. The present data demonstrates that
increased circulating IL-13 may be associated with venti-
lation function impairment, which supports our theory
t h a tI L - 1 3p l a y sar o l ei nt h ep a t h o g e n e s i so fl u n g
inflammatory and alveolar remodeling in pneumonoco-
niosis and provides evidence that Th2 cell polarization
involving IL-13 may favor the development of pulmon-
ary fibrosis [12,14,37].
T h ed a t ao fo u rs t u d ys h o w st h a tt h es e r u ml e v e l so f
IL-18R are positively associated with changes in FEV1
levels in the patients with CWP, suggesting a relation-
ship between levels of IL-18R and ventilation function
impairment in these miners. These results were most
consistent with an experimental model in which IL-18R
was upregulated during differentiation along the Th1
pathway while IL-18R was downregulated during Th2
differentiation [41]. We also found that IL-18R levels
had a slight inverse trend with all of the alterations in
lung ventilation function parameters in asymptomatic
miners. These results provide evidence that the changes
of serum IL-18R levels may concomitantly participate in
the occurrence and development of CWP in miners.
It was previously reported that IL-18 and IL-18R may
be involved in the pathogenesis of pulmonary fibrosis
[42]. Other studies have shown that IL-18 serum levels
have a trend to inversely correlate with peak expiratory
flow [43]. Results of the present study did not show a
significant relationship between IL-18 levels and ventila-
tion function parameters, except in asymptomatic
miners. These results may indicate that IL-18 is involved
in lung function alteration indirectly, perhaps via influ-
encing from Th1 and Th2 cell responses or other inte-
grated mechanisms [41,44].
This study also revealed that serum levels of both
sCD40 and sCD40L showed trends towards inverse cor-
relations with all ventilation functional parameters in
the asymptomatic group and miners with CWP. Also,
there were inverse correlations between the sCD40L
levels and lung function in the CWP group, and positive
correlations between sCD40L and lung function altera-
tions in group 0+. If there had been more participants
in this study these associations could possibly have been
more significant. From our data analysis, we propose
that the CD40:CD40L pathway may be involved in the
perpetuation of inflammatory, wound healing responses
and fibrosis formation, and that these changes might be
activated by infiltrating T lymphocytes that facilitate
both cellular and humoral immune responses in the
lungs of the miners [45].
Our study also indicated that concentrations of
sICAM-1 in serum were inversely correlated with all of
the lung ventilation function parameters in the asympto-
matic miners. This data implies that there may be a cor-
relation between sICAM-1 and lung function
impairment. The sICAM-1 may be elaborated via a
mechanism involving ICAM-1 inducing inflammatory
responses involving monocyte migration and neutrophil
influx in the lungs of the miners [46].
With respect to the cytokines IL-8, IL-9, IL-1b and
MCP-1, which are known to be important in initiation
and maintenance of inflammatory processes and pul-
monary fibrosis [7,8,45], the levels of these biomarkers
showed no correlations with changes in lung ventilation
function parameters in the three groups of miners in
our studies. This suggests that these serum biomarkers
may have no direct correlation with ventilation function
impairment in these coal mine workers.
Conclusions
T h ed a t ai nt h i ss t u d yp r o v i d ee v i d e n c et h a tt h ea l t e r a -
tions of lung ventilation functional parameters in non-
smoking coal workers are associated with changes in
serum MMP-9, TIMP-9, IL-13, and IL-18R levels. These
circulatory biomarkers may play roles in the progression
of the development of pulmonary function impairments
in coal miners. The levels of MMP-9, TIMP-9 and IL-13
m a yb em o n i t o r e da sp o s s i b le markers to estimate or
predict lung function changes in minimally symptomatic
coal miners. In addition, our study supports suggestions
that intervention against changes of MMP-9, TIMP-9,
IL-13 and IL-18R levels are warranted to facilitate
diminished risk of pulmonary injury in coal workers.
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